Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
  1. 4 Insider Changes in Ownership
  2. 4 Grant or award Chief Commercial Officer acquired 67,114 shares (grant or award)
  3. 4 Open-market sale General Counsel sold 965 shares at $1.48 ($1,428)
  4. 4 Open-market sale Chief Scientific Officer sold 1,439 shares at $1.48 ($2,130)
  5. 4 Grant or award General Counsel acquired 3,703 shares (grant or award)
  6. 4 Grant or award Chief Scientific Officer acquired 3,703 shares (grant or award)
  7. 4 Open-market sale Chief Financial Officer sold 6,680 shares at an average $1.44 ($9,600)
  8. 4 Open-market sale Chief Data Officer sold 1,311 shares at $1.48 ($1,940)
  9. 4 Open-market sale Chief Information Officer sold 667 shares at $1.48 ($987)
  10. 4 Open-market sale Chief Executive Officer sold 26,386 shares at an average $1.44 ($37,899)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Grant or award Director acquired 15,596 shares (grant or award)
  14. 4 Grant or award Director acquired 15,596 shares (grant or award)
  15. 4 Open-market sale Director sold 107 shares at $1.58 ($169)
  16. 4 Grant or award Director acquired 15,596 shares (grant or award)
  17. 4 Grant or award Director acquired 15,596 shares (grant or award)
  18. 4 Grant or award Director acquired 15,596 shares (grant or award)
  19. 4 Grant or award Director acquired 15,596 shares (grant or award)
  20. 4 Open-market sale Director sold 106 shares at $2.44 ($259)

Page 6 of 16 · 313 filings